Fahad Al-Jalajel was recently appointed chairman of the board of directors at the Saudi Food and Drug Authority following a royal decree.
He has been Saudi Arabia’s health minister since October 2021 and was deputy health minister from 2016.
He has been a member of the board of directors at the Saudi Red Crescent Authority since May 2017 and a member of the board of directors at the SFDA since July that same year.
He is a member of the executive council of the country’s medical cities, a council member at the Saudi General Authority for Competition from 2011 to 2018, and a member of the board of directors at Saudia from 2015 to 2017.
Al-Jalajel was a member of the board of directors at the Saudi Grains Authority from 2013 to 2017 and a member of the board of directors at the Human Resources Development Fund from 2011 to 2016.
He was a member of the board of directors at the Saudi Arabian General Investment Authority (now the Ministry of Investment) from 2014 to 2016 and a member of the board of directors at the Saudi Standards, Metrology and Quality Organization from 2012 to 2016.
Al-Jalajel was deputy minister for consumer protection at the Ministry of Commerce and Investment (now the Ministry of Commerce) from 2011 to 2016 and was also its chief information officer and ministerial adviser.
He was a member of the Riyadh Regional Council from 2010 to 2012 and a member of the board of directors at the Saudi Commission for Tourism and National Heritage (now the Ministry of Tourism) from 2010 to 2012.
He was a member of the Saudi Energy Efficiency Program, a member of the board of directors at the Jeddah Urban Development Co., and an IT director at SAGIA.
He has a master’s degree in computer and information sciences from St. Joseph’s University in the US. He completed an executive program at MIT’s Sloan School of Management and has a bachelor’s degree in computer science from King Saud University.
